BiotechTube

Vemurafenib + Sorafenib

Phase 2Active
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pancreas Cancer

Conditions

Pancreas Cancer

Trial Timeline

Oct 28, 2021 → Dec 30, 2024

NCT ID
NCT05068752

About Vemurafenib + Sorafenib

Vemurafenib + Sorafenib is a phase 2 stage product being developed by Bayer for Pancreas Cancer. The current trial status is active. This product is registered under clinical trial identifier NCT05068752. Target conditions include Pancreas Cancer.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT05068752Phase 2Active

Competing Products

20 competing products in Pancreas Cancer

See all competitors
ProductCompanyStageHype Score
pemetrexedEli LillyPhase 2
52
Alemtuzumab + Rabbit Anti-Human Thymocyte GlobulinAstellas PharmaPhase 3
77
Romidepsin + Azacitidine + nab-Paclitaxel + Gemcitabine + Durvalumab + Lenalidomide capsuleAstraZenecaPhase 1/2
41
DurvalumabAstraZenecaPhase 2
52
MK-2206MerckPhase 2
52
Pembrolizumab + DEBIO1143MerckPhase 1
33
dovitinib lactate + gemcitabine hydrochloride + capecitabineNovartisPhase 1
33
AUY922NovartisPhase 2
52
dovitinib lactate + gemcitabine hydrochloride + paclitaxel albumin-stabilized nanoparticle formulationNovartisPhase 1
33
FOLFIRINOX + Oxaliplatin + Leucovorin + Irinotecan + 5-Fluorouracil (5-FU) + NIS793 + CapecitabineNovartisPhase 1
33
Enteric-coated mycophenolate sodium (EC-MPS)NovartisPhase 3
77
DaclizumabRocheApproved
85
Gemcitabine + panitumumabAmgenPhase 2
51
PF-03084014 + Gemcitabine + Nab-paclitaxel + PF-03084014 + Gemcitabine + Nab-paclitaxel + Gemcitabine + Nab-paclitaxelPfizerPhase 2
51
CRS-207 + CRS-207 + nivolumab + GVAX + CYBristol Myers SquibbPhase 2
51
Belatacept + methylprednisolone + Anti-thymocyte Globulin (Rabbit) + Tacrolimus + Mycophenolate mofetilBristol Myers SquibbPhase 2
51
AK154 + Cadonilimab + Ivonescimab (SMT112 or AK112) Injection + mFOLFORINOXAkesoPhase 1
32
sorafenib tosylate + everolimusBayerPhase 1
30
Pemigatinib 4.5 MGIncytePhase 2
49
Irinotecan Liposomal Injection + Oxaliplatin + 5Fluorouracil + Leucovorin + Nab-paclitaxel + GemcitabineIpsenPhase 3
74

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82